

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to type I interferon (GO:0071357) | 5.11017248 |
| 2 | type I interferon signaling pathway (GO:0060337) | 5.11017248 |
| 3 | response to type I interferon (GO:0034340) | 5.10177816 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.01183735 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.92516868 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.92516868 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.88345464 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.82898805 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.79170784 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.76868195 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.84160707 |
| 12 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.76947543 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 3.67196372 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 3.66005316 |
| 15 | detection of bacterium (GO:0016045) | 3.64885789 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.61733276 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 3.61733276 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 3.61733276 |
| 19 | modulation by symbiont of host defense response (GO:0052031) | 3.61733276 |
| 20 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.61733276 |
| 21 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.61733276 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 3.60527404 |
| 23 | detection of other organism (GO:0098543) | 3.57594731 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 3.54725529 |
| 25 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.53742040 |
| 26 | regulation of T cell tolerance induction (GO:0002664) | 3.53461859 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.45028331 |
| 28 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.44067735 |
| 29 | response to peptidoglycan (GO:0032494) | 3.42962076 |
| 30 | germinal center formation (GO:0002467) | 3.39242247 |
| 31 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.33960743 |
| 32 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.32710404 |
| 33 | regulation of interferon-alpha production (GO:0032647) | 3.32253635 |
| 34 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.30750099 |
| 35 | T cell migration (GO:0072678) | 3.30253520 |
| 36 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29698412 |
| 37 | negative regulation of viral genome replication (GO:0045071) | 3.28913080 |
| 38 | response to interferon-alpha (GO:0035455) | 3.26555463 |
| 39 | defense response to protozoan (GO:0042832) | 3.26254367 |
| 40 | response to interferon-beta (GO:0035456) | 3.26077131 |
| 41 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.25303928 |
| 42 | NIK/NF-kappaB signaling (GO:0038061) | 3.24607521 |
| 43 | positive regulation of interferon-alpha production (GO:0032727) | 3.20405269 |
| 44 | regulation of regulatory T cell differentiation (GO:0045589) | 3.20194309 |
| 45 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.17251495 |
| 46 | response to muramyl dipeptide (GO:0032495) | 3.16420450 |
| 47 | regulation of tolerance induction (GO:0002643) | 3.12547093 |
| 48 | response to protozoan (GO:0001562) | 3.12356965 |
| 49 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.10817806 |
| 50 | negative regulation of innate immune response (GO:0045824) | 3.09263096 |
| 51 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.07500226 |
| 52 | positive regulation of tolerance induction (GO:0002645) | 3.06946972 |
| 53 | regulation of antigen processing and presentation (GO:0002577) | 3.06774212 |
| 54 | negative thymic T cell selection (GO:0045060) | 3.06535007 |
| 55 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.05960015 |
| 56 | myeloid dendritic cell differentiation (GO:0043011) | 3.05574363 |
| 57 | detection of external biotic stimulus (GO:0098581) | 3.05265850 |
| 58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.03721571 |
| 59 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.01679275 |
| 60 | positive regulation of type 2 immune response (GO:0002830) | 3.00890557 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 3.00829008 |
| 62 | leukocyte aggregation (GO:0070486) | 2.99717154 |
| 63 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.96782976 |
| 64 | positive thymic T cell selection (GO:0045059) | 2.95817943 |
| 65 | response to interleukin-15 (GO:0070672) | 2.95587501 |
| 66 | negative T cell selection (GO:0043383) | 2.95543763 |
| 67 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.91325386 |
| 68 | neutrophil activation involved in immune response (GO:0002283) | 2.89804986 |
| 69 | tolerance induction (GO:0002507) | 2.89546551 |
| 70 | cellular response to interferon-gamma (GO:0071346) | 2.88158097 |
| 71 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.87089870 |
| 72 | B cell receptor signaling pathway (GO:0050853) | 2.83839390 |
| 73 | regulation of type 2 immune response (GO:0002828) | 2.83422543 |
| 74 | myeloid dendritic cell activation (GO:0001773) | 2.81792933 |
| 75 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.78584576 |
| 76 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.78584576 |
| 77 | T-helper 1 type immune response (GO:0042088) | 2.77679876 |
| 78 | cellular response to interleukin-15 (GO:0071350) | 2.75953254 |
| 79 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.73650530 |
| 80 | B cell mediated immunity (GO:0019724) | 2.73177931 |
| 81 | negative regulation of type 2 immune response (GO:0002829) | 2.70950640 |
| 82 | response to interferon-gamma (GO:0034341) | 2.70462086 |
| 83 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.69604009 |
| 84 | thymic T cell selection (GO:0045061) | 2.69065051 |
| 85 | positive regulation of humoral immune response (GO:0002922) | 2.68495112 |
| 86 | detection of molecule of bacterial origin (GO:0032490) | 2.67829805 |
| 87 | cellular response to exogenous dsRNA (GO:0071360) | 2.67384467 |
| 88 | cellular response to interferon-beta (GO:0035458) | 2.65970124 |
| 89 | myeloid cell activation involved in immune response (GO:0002275) | 2.64792301 |
| 90 | response to host immune response (GO:0052572) | 2.64409502 |
| 91 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.64409502 |
| 92 | interferon-gamma secretion (GO:0072643) | 2.63743971 |
| 93 | detection of biotic stimulus (GO:0009595) | 2.63478387 |
| 94 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.62041908 |
| 95 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.61882167 |
| 96 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.61633835 |
| 97 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.60857287 |
| 98 | T cell selection (GO:0045058) | 2.59700081 |
| 99 | interferon-gamma production (GO:0032609) | 2.59597684 |
| 100 | regulation of interleukin-12 production (GO:0032655) | 2.58864013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.63075545 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.30969284 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.76158145 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.64695575 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.64174463 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.47658938 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.95425746 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.66853273 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.55663728 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54772069 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.54397384 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.33189112 |
| 13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32526568 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26152843 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.22307729 |
| 16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.21847802 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.19824424 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.19070697 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.15906813 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.13642040 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.11594952 |
| 22 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01950999 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.99880545 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 1.93888018 |
| 25 | MYC_22102868_ChIP-Seq_BL_Human | 1.88589368 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.87302309 |
| 27 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.86833928 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.80175491 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79025715 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 1.78614484 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.77147720 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75207001 |
| 33 | MAF_26560356_Chip-Seq_TH2_Human | 1.72188324 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.71103373 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.70209199 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67725550 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65990370 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65631151 |
| 39 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65012457 |
| 40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.63904802 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62996278 |
| 42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61808072 |
| 43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.61786608 |
| 44 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.58909487 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58635274 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56297283 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.54820785 |
| 48 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50705951 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.48197857 |
| 50 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.44927254 |
| 51 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.42041067 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38400111 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38123119 |
| 54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33730869 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.32717570 |
| 56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31138876 |
| 57 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.30759411 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.30291260 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.28763339 |
| 60 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.27456959 |
| 61 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25310246 |
| 62 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.25099664 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24387265 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23465322 |
| 65 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.20538420 |
| 66 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18607749 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16945217 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16365702 |
| 69 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16110447 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15095312 |
| 71 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14810431 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14735017 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14564626 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14032637 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 1.12883159 |
| 76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11531910 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11307447 |
| 78 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08824088 |
| 79 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07407550 |
| 80 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.03994216 |
| 81 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03904938 |
| 82 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03783069 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03291036 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01752963 |
| 85 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.01032996 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00723652 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.99228840 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.99012958 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.98237832 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98129602 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97984058 |
| 92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97829055 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.96423228 |
| 94 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95295997 |
| 95 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95006835 |
| 96 | * P68_20966046_ChIP-Seq_HELA_Human | 0.95001954 |
| 97 | GATA1_22025678_ChIP-Seq_K562_Human | 0.94527027 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93074670 |
| 99 | SA1_27219007_Chip-Seq_Bcells_Human | 0.92710750 |
| 100 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92668500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.82980107 |
| 2 | MP0003303_peritoneal_inflammation | 3.82661077 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.82239753 |
| 4 | MP0003724_increased_susceptibility_to | 3.80898961 |
| 5 | MP0009785_altered_susceptibility_to | 3.25347090 |
| 6 | MP0005671_abnormal_response_to | 3.20906619 |
| 7 | MP0005387_immune_system_phenotype | 3.11408044 |
| 8 | MP0001790_abnormal_immune_system | 3.11408044 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.98118826 |
| 10 | MP0001800_abnormal_humoral_immune | 2.88145209 |
| 11 | MP0000685_abnormal_immune_system | 2.81502520 |
| 12 | MP0005025_abnormal_response_to | 2.80219994 |
| 13 | MP0006082_CNS_inflammation | 2.71612955 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.66944140 |
| 15 | MP0002419_abnormal_innate_immunity | 2.56994107 |
| 16 | MP0002723_abnormal_immune_serum | 2.55726009 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.41046761 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 2.35145086 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.28609975 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.24205645 |
| 21 | MP0001819_abnormal_immune_cell | 2.23614464 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.23180148 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 2.12036620 |
| 24 | MP0010155_abnormal_intestine_physiology | 2.10268782 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.09448312 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.91352007 |
| 27 | MP0004510_myositis | 1.90592351 |
| 28 | MP0004947_skin_inflammation | 1.86296483 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.84227477 |
| 30 | MP0009764_decreased_sensitivity_to | 1.80889106 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.80575602 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.77681761 |
| 33 | MP0002405_respiratory_system_inflammati | 1.75108315 |
| 34 | MP0000716_abnormal_immune_system | 1.73141702 |
| 35 | MP0003191_abnormal_cellular_cholesterol | 1.72997875 |
| 36 | MP0008469_abnormal_protein_level | 1.69378452 |
| 37 | MP0009840_abnormal_foam_cell | 1.68722808 |
| 38 | MP0002398_abnormal_bone_marrow | 1.68008629 |
| 39 | MP0003172_abnormal_lysosome_physiology | 1.64137673 |
| 40 | MP0005360_urolithiasis | 1.46816470 |
| 41 | MP0003075_altered_response_to | 1.42259775 |
| 42 | MP0009278_abnormal_bone_marrow | 1.40794336 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.39743672 |
| 44 | MP0005451_abnormal_body_composition | 1.38640609 |
| 45 | MP0002429_abnormal_blood_cell | 1.34094942 |
| 46 | MP0002998_abnormal_bone_remodeling | 1.32138349 |
| 47 | MP0002722_abnormal_immune_system | 1.31290661 |
| 48 | MP0002933_joint_inflammation | 1.28259557 |
| 49 | MP0000604_amyloidosis | 1.26672417 |
| 50 | MP0005310_abnormal_salivary_gland | 1.25281649 |
| 51 | MP0003866_abnormal_defecation | 1.24227664 |
| 52 | MP0001853_heart_inflammation | 1.23375216 |
| 53 | MP0005166_decreased_susceptibility_to | 1.22837901 |
| 54 | MP0005365_abnormal_bile_salt | 1.22603072 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.20849873 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.20849873 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.16449130 |
| 58 | MP0001873_stomach_inflammation | 1.15058156 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.14242567 |
| 60 | MP0000858_altered_metastatic_potential | 1.13462301 |
| 61 | MP0003195_calcinosis | 1.12832343 |
| 62 | MP0009763_increased_sensitivity_to | 1.07188340 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.05370764 |
| 64 | MP0000703_abnormal_thymus_morphology | 1.04860582 |
| 65 | MP0001851_eye_inflammation | 1.02964216 |
| 66 | MP0003448_altered_tumor_morphology | 1.01338562 |
| 67 | MP0000343_altered_response_to | 0.98918494 |
| 68 | MP0003690_abnormal_glial_cell | 0.96417094 |
| 69 | MP0003045_fibrosis | 0.94218109 |
| 70 | MP0005390_skeleton_phenotype | 0.92350451 |
| 71 | MP0008260_abnormal_autophagy | 0.91782931 |
| 72 | MP0005085_abnormal_gallbladder_physiolo | 0.89975672 |
| 73 | MP0002006_tumorigenesis | 0.89139995 |
| 74 | MP0005164_abnormal_response_to | 0.89132390 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 0.88461658 |
| 76 | MP0001663_abnormal_digestive_system | 0.87087881 |
| 77 | MP0008874_decreased_physiological_sensi | 0.87046785 |
| 78 | MP0008875_abnormal_xenobiotic_pharmacok | 0.87020153 |
| 79 | MP0002254_reproductive_system_inflammat | 0.82985672 |
| 80 | MP0003252_abnormal_bile_duct | 0.82581725 |
| 81 | MP0005167_abnormal_blood-brain_barrier | 0.79946552 |
| 82 | MP0004883_abnormal_blood_vessel | 0.79283826 |
| 83 | MP0000609_abnormal_liver_physiology | 0.78555870 |
| 84 | MP0002132_abnormal_respiratory_system | 0.77539631 |
| 85 | MP0000249_abnormal_blood_vessel | 0.77013347 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.76440717 |
| 87 | MP0008004_abnormal_stomach_pH | 0.76002640 |
| 88 | MP0002396_abnormal_hematopoietic_system | 0.73205238 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.69002036 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.67637468 |
| 91 | MP0003795_abnormal_bone_structure | 0.66018610 |
| 92 | MP0005319_abnormal_enzyme/_coenzyme | 0.65748509 |
| 93 | MP0001501_abnormal_sleep_pattern | 0.65728742 |
| 94 | MP0005535_abnormal_body_temperature | 0.64903610 |
| 95 | MP0003828_pulmonary_edema | 0.64595183 |
| 96 | MP0001542_abnormal_bone_strength | 0.62603349 |
| 97 | MP0002118_abnormal_lipid_homeostasis | 0.61734208 |
| 98 | MP0005023_abnormal_wound_healing | 0.61015017 |
| 99 | MP0004808_abnormal_hematopoietic_stem | 0.61003463 |
| 100 | MP0001764_abnormal_homeostasis | 0.60121789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 4.85852984 |
| 2 | Orchitis (HP:0100796) | 4.75969444 |
| 3 | Retrobulbar optic neuritis (HP:0100654) | 4.71790108 |
| 4 | Optic neuritis (HP:0100653) | 4.71790108 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.57107133 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.24168702 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.93247068 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.88423056 |
| 9 | Stomatitis (HP:0010280) | 3.86380670 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.84956379 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76854792 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 3.76419023 |
| 13 | Meningitis (HP:0001287) | 3.67799251 |
| 14 | Vasculitis (HP:0002633) | 3.59129658 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.52795945 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.48882620 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.45038691 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.34707553 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.34707553 |
| 20 | Abnormality of glycolipid metabolism (HP:0010969) | 3.34707553 |
| 21 | Pulmonary infiltrates (HP:0002113) | 3.31476218 |
| 22 | Keratoconjunctivitis sicca (HP:0001097) | 3.27377275 |
| 23 | Complement deficiency (HP:0004431) | 3.25805430 |
| 24 | Encephalitis (HP:0002383) | 3.25188077 |
| 25 | Increased IgE level (HP:0003212) | 3.15131634 |
| 26 | Recurrent viral infections (HP:0004429) | 3.14553534 |
| 27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.09567106 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.09567106 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 3.09020150 |
| 30 | T lymphocytopenia (HP:0005403) | 3.03456993 |
| 31 | Keratoconjunctivitis (HP:0001096) | 3.01600341 |
| 32 | Increased IgM level (HP:0003496) | 2.97540249 |
| 33 | Hemoptysis (HP:0002105) | 2.94414471 |
| 34 | Abnormality of T cell number (HP:0011839) | 2.92523136 |
| 35 | Obstructive lung disease (HP:0006536) | 2.92410078 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 2.92410078 |
| 37 | Abnormality of complement system (HP:0005339) | 2.90797934 |
| 38 | Recurrent skin infections (HP:0001581) | 2.90632171 |
| 39 | Gastrointestinal stroma tumor (HP:0100723) | 2.87362435 |
| 40 | Agammaglobulinemia (HP:0004432) | 2.84010403 |
| 41 | Purpura (HP:0000979) | 2.83775463 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.83145271 |
| 43 | Panhypogammaglobulinemia (HP:0003139) | 2.80944764 |
| 44 | Pustule (HP:0200039) | 2.80651402 |
| 45 | Recurrent bronchitis (HP:0002837) | 2.80461242 |
| 46 | Colitis (HP:0002583) | 2.76972383 |
| 47 | Pulmonary embolism (HP:0002204) | 2.75934659 |
| 48 | Gingival bleeding (HP:0000225) | 2.68589536 |
| 49 | Glomerulonephritis (HP:0000099) | 2.68546028 |
| 50 | Abnormality of T cells (HP:0002843) | 2.62089577 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.61584828 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.61542241 |
| 53 | Deep venous thrombosis (HP:0002625) | 2.60236967 |
| 54 | Gingivitis (HP:0000230) | 2.55160398 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.55083293 |
| 56 | Gangrene (HP:0100758) | 2.54660132 |
| 57 | Hypergammaglobulinemia (HP:0010702) | 2.54005168 |
| 58 | Joint swelling (HP:0001386) | 2.51652328 |
| 59 | Emphysema (HP:0002097) | 2.50442121 |
| 60 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.49966135 |
| 61 | Cellulitis (HP:0100658) | 2.49141633 |
| 62 | Increased serum ferritin (HP:0003281) | 2.48533234 |
| 63 | Arterial thrombosis (HP:0004420) | 2.47724547 |
| 64 | Epistaxis (HP:0000421) | 2.47058419 |
| 65 | Loss of speech (HP:0002371) | 2.46471273 |
| 66 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.44200505 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.44200505 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.44200505 |
| 69 | Autoimmune hemolytic anemia (HP:0001890) | 2.42657213 |
| 70 | Prolonged bleeding time (HP:0003010) | 2.42608439 |
| 71 | Abnormality of the pleura (HP:0002103) | 2.40248826 |
| 72 | Urticaria (HP:0001025) | 2.38923904 |
| 73 | Lymphopenia (HP:0001888) | 2.37296216 |
| 74 | Autoimmune thrombocytopenia (HP:0001973) | 2.36699499 |
| 75 | Anorexia (HP:0002039) | 2.32962561 |
| 76 | Petechiae (HP:0000967) | 2.29082647 |
| 77 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27816178 |
| 78 | Mucopolysacchariduria (HP:0008155) | 2.27816178 |
| 79 | Abnormality of T cell physiology (HP:0011840) | 2.26680683 |
| 80 | Chronic otitis media (HP:0000389) | 2.25820326 |
| 81 | Joint hemorrhage (HP:0005261) | 2.25445117 |
| 82 | Increased cerebral lipofuscin (HP:0011813) | 2.23728876 |
| 83 | Leukocytosis (HP:0001974) | 2.22018357 |
| 84 | Granulocytopenia (HP:0001913) | 2.21682080 |
| 85 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.21126280 |
| 86 | Chest pain (HP:0100749) | 2.17653637 |
| 87 | Abnormality of iron homeostasis (HP:0011031) | 2.16585673 |
| 88 | IgG deficiency (HP:0004315) | 2.15749672 |
| 89 | Vacuolated lymphocytes (HP:0001922) | 2.14106877 |
| 90 | Hyperlipoproteinemia (HP:0010980) | 2.13310524 |
| 91 | Episodic fever (HP:0001954) | 2.10912436 |
| 92 | Acne (HP:0001061) | 2.09069437 |
| 93 | Hypochromic anemia (HP:0001931) | 2.08345191 |
| 94 | Arthralgia (HP:0002829) | 2.07184640 |
| 95 | Abnormality of B cell number (HP:0010975) | 2.05202641 |
| 96 | Abnormality of the nasal mucosa (HP:0000433) | 2.03138940 |
| 97 | Nasal polyposis (HP:0100582) | 1.99551410 |
| 98 | Restrictive lung disease (HP:0002091) | 1.99320535 |
| 99 | Amyloidosis (HP:0011034) | 1.98567695 |
| 100 | Abnormality of the pericardium (HP:0001697) | 1.97066803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.43649639 |
| 2 | RIPK4 | 3.40518216 |
| 3 | TYK2 | 3.11087106 |
| 4 | ERN1 | 2.97123628 |
| 5 | PRPF4B | 2.76219297 |
| 6 | IKBKE | 2.63580994 |
| 7 | MAP3K14 | 2.54623519 |
| 8 | TBK1 | 2.54126856 |
| 9 | JAK3 | 2.35921220 |
| 10 | TXK | 2.35238802 |
| 11 | BLK | 2.16990143 |
| 12 | JAK1 | 2.07292798 |
| 13 | IRAK4 | 1.98999335 |
| 14 | ZAP70 | 1.94883669 |
| 15 | FGFR4 | 1.92242150 |
| 16 | KIT | 1.89310242 |
| 17 | TNK2 | 1.82841336 |
| 18 | FES | 1.82381853 |
| 19 | CSK | 1.75488763 |
| 20 | IKBKB | 1.67538328 |
| 21 | TAOK3 | 1.64855292 |
| 22 | SYK | 1.64012801 |
| 23 | MAP3K11 | 1.63531152 |
| 24 | BTK | 1.56228668 |
| 25 | MAP2K3 | 1.53274055 |
| 26 | RIPK1 | 1.51744330 |
| 27 | MAP3K13 | 1.50429719 |
| 28 | TRIB3 | 1.48246162 |
| 29 | IRAK3 | 1.41247038 |
| 30 | GRK6 | 1.38948517 |
| 31 | SIK3 | 1.37574115 |
| 32 | EPHB1 | 1.33966545 |
| 33 | CSF1R | 1.33081652 |
| 34 | CDC42BPA | 1.29709033 |
| 35 | MATK | 1.28220585 |
| 36 | SIK2 | 1.27737820 |
| 37 | TAOK2 | 1.26900626 |
| 38 | LYN | 1.23330468 |
| 39 | ITK | 1.23083568 |
| 40 | LCK | 1.22004000 |
| 41 | HCK | 1.19146998 |
| 42 | SIK1 | 1.16923526 |
| 43 | BMPR2 | 1.15718711 |
| 44 | MAP3K3 | 1.14421957 |
| 45 | FGFR3 | 1.08162686 |
| 46 | GRK7 | 1.06179114 |
| 47 | JAK2 | 1.01585818 |
| 48 | HIPK2 | 0.99226126 |
| 49 | MAPK7 | 0.97085368 |
| 50 | TESK2 | 0.96146342 |
| 51 | MAP3K1 | 0.95616170 |
| 52 | FGR | 0.91334753 |
| 53 | TAOK1 | 0.88205322 |
| 54 | TEC | 0.87618780 |
| 55 | MARK3 | 0.85835150 |
| 56 | PRKD2 | 0.84723816 |
| 57 | MAPK11 | 0.84407777 |
| 58 | PDK1 | 0.76533128 |
| 59 | MAP2K6 | 0.74887282 |
| 60 | CHUK | 0.74490138 |
| 61 | PRKCQ | 0.74237234 |
| 62 | DDR2 | 0.74225669 |
| 63 | MAPK12 | 0.73720039 |
| 64 | IRAK1 | 0.71333648 |
| 65 | MARK2 | 0.69271596 |
| 66 | TGFBR2 | 0.68170363 |
| 67 | NME2 | 0.66297022 |
| 68 | KDR | 0.64246244 |
| 69 | CAMKK1 | 0.60842446 |
| 70 | DAPK2 | 0.58394606 |
| 71 | PDPK1 | 0.58271431 |
| 72 | EPHA3 | 0.58211586 |
| 73 | SMG1 | 0.53573265 |
| 74 | PIM2 | 0.53359693 |
| 75 | PIM1 | 0.52074123 |
| 76 | ADRBK2 | 0.51523582 |
| 77 | MAP3K7 | 0.50098810 |
| 78 | FYN | 0.48316463 |
| 79 | MAP2K2 | 0.47301684 |
| 80 | STK10 | 0.43125858 |
| 81 | PRKCH | 0.42463592 |
| 82 | MAPK4 | 0.41220075 |
| 83 | NEK9 | 0.40403603 |
| 84 | RPS6KC1 | 0.38626220 |
| 85 | RPS6KL1 | 0.38626220 |
| 86 | IRAK2 | 0.38118221 |
| 87 | MOS | 0.38052839 |
| 88 | CDK4 | 0.34253048 |
| 89 | MAPKAPK2 | 0.32611139 |
| 90 | RPS6KA6 | 0.32119090 |
| 91 | CAMKK2 | 0.31421210 |
| 92 | PTK6 | 0.30712677 |
| 93 | TYRO3 | 0.30208275 |
| 94 | ABL1 | 0.29958528 |
| 95 | MAPK3 | 0.29562058 |
| 96 | PTK2B | 0.29140942 |
| 97 | NLK | 0.27580929 |
| 98 | RPS6KA2 | 0.27228769 |
| 99 | DYRK1B | 0.26933178 |
| 100 | PRKG2 | 0.26307326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.21263518 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.99244500 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.86547292 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.86202895 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.74631363 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.50179714 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.45516795 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.36195911 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.29758717 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.28263281 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.25937915 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.25641096 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.24979701 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.17411511 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 2.04002858 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.86612096 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.85822599 |
| 18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.82450352 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.71332404 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.68914867 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66686294 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.65091117 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.64330865 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.63798966 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.61711836 |
| 26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.60040042 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59189457 |
| 28 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.56833372 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.55650965 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.54180249 |
| 31 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.53773239 |
| 32 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.46899141 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.46394210 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.44006483 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38927965 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.32962071 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22366113 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20205604 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15498778 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15484523 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12968445 |
| 42 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.12095002 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.09206435 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.00144949 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97726115 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 0.97472313 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 0.96790267 |
| 48 | Hepatitis B_Homo sapiens_hsa05161 | 0.96772066 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 0.87545458 |
| 50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83660533 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.77817104 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.76234820 |
| 53 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.73657646 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.73325366 |
| 55 | Apoptosis_Homo sapiens_hsa04210 | 0.72406890 |
| 56 | Shigellosis_Homo sapiens_hsa05131 | 0.71405253 |
| 57 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68469384 |
| 58 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64509021 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62485444 |
| 60 | Platelet activation_Homo sapiens_hsa04611 | 0.62458053 |
| 61 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62225705 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59950775 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59654100 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58459573 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.57336712 |
| 66 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56345537 |
| 67 | Insulin resistance_Homo sapiens_hsa04931 | 0.49829804 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49632623 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49292749 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44214408 |
| 71 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43356596 |
| 72 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39869444 |
| 73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39400724 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38336816 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38292157 |
| 76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.37674627 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36330986 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.35993923 |
| 79 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35045312 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34898698 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.34695493 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34448875 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.34345523 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.34316115 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34041449 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31336025 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30736868 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30267130 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.30112327 |
| 90 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.26141998 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25549908 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25251356 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.24484822 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23359480 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23328982 |
| 96 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23273401 |
| 97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20240990 |
| 98 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.19825921 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.19613068 |
| 100 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.19587391 |

